GCM
AMGN icon

Genus Capital Management’s Amgen AMGN Stock Holding History

Genus Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,795
Closed -$1.5M – 193
2024
Q2 		$1.5M Buy
+4,795
New +$1.41M 0.2% 120
2024
Q1 		– Sell
-20,395
Closed -$5.87M – 208
2023
Q4 		$5.87M Buy
+20,395
New +$5.56M 0.86% 37

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Genus Capital Management's AMGN Position: Q1 2026 in Review

Genus Capital Management increased its Amgen (AMGN) stake by 3,987% in Q1 2026, buying an estimated $15.5M and bringing the position to 44,427 shares worth $15.6M. The position accounts for 1.79% of the portfolio, ranked #11.

Genus Capital Management first reported a position in AMGN in Q2 2023 and has held it in 7 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Genus Capital Management held 44,427 shares of Amgen worth $15.6M as of Q1 2026.
  • Genus Capital Management bought 43,340 Amgen shares in Q1 2026, an estimated $15.5M.
  • Amgen made up 1.79% of Genus Capital Management's portfolio in Q1 2026, its #11 holding.
  • Genus Capital Management first reported a position in Amgen in Q2 2023 and has held it in 7 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.